Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Aequus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Aequus Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Aequus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Aequus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Aequus Pharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 10
Aequus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Aequus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details 13
Venture Financing 13
Aequus Pharma Raises USD0.6 Million in Venture Financing 13
Aequus Pharma Raises US$1.2 Million In First Round Of Venture Financing 14
Partnerships 15
Aequus Pharma Enters into Agreement with Ehave 15
CannaRoyalty and Aequus Pharma Enter into Agreement 16
Aequus Pharma to Enter into Agreement with Scientus Pharma 17
Aequus Pharma Enters into Agreement with Santen 18
Aequus Pharma and Centre for Drug Research and Development Enter into a Research Agreement 19
Aequus Pharma Enters into Co-Development Agreement with Corium International 20
Aequus Pharma Enters into Co-Development Agreement with Corium International 21
Licensing Agreements 22
Aequus Pharma to Enter into Licensing Agreement with Transdermal Research Pharm Labs 22
Aequus Pharma Enters into Licensing Agreement with Supernus Pharma 23
Aequus Pharma Enters Into Licensing Agreement With Transdermal Research Pharm Labs For Transdermal Delivery Of Aripiprazole 24
Equity Offering 25
Aequus Pharma Raises USD0.2 Million in Private Placement of Units 25
Aequus Pharma Raises USD0.6 Million in Private Placement of Units 26
Aequus Raises USD0.2 Million in Private Placement of Units 28
Aequus Pharma Plans to Raise up to USD15.7 Million in Public Offering 29
Aequus Pharma Raises USD3.9 Million in Public Offering of Units 30
Aequus Pharma Raises USD2 Million in Public Offering of Shares 32
Aequus Pharma Raises USD1.3 Million in Public Offering of Shares 33
Aequus Pharma Raises USD0.6 Million in Private Placement of Shares 34
Aequus Pharma Raises USD1 Million in Public Offering of Shares 35
Aequus Pharma Raises USD3.3 Million in Private Placement of Warrants 36
Aequus Pharma Raises USD0.4 Million in Private Placement of Warrants 37
Acquisition 38
Aequus Pharma Acquires TeOra Health 38
Aequus Pharmaceuticals Inc – Key Competitors 39
Aequus Pharmaceuticals Inc – Key Employees 40
Aequus Pharmaceuticals Inc – Locations And Subsidiaries 41
Head Office 41
Other Locations & Subsidiaries 41
Recent Developments 42
Financial Announcements 42
May 31, 2018: Aequus Provides First Quarter 2018 Financial and Corporate Highlights 42
Apr 27, 2018: Aequus Pharmaceuticals Reports Fourth Quarter and Fiscal 2017 Financial Highlights 44
Nov 29, 2017: Aequus Provides Third Quarter 2017 Operational Highlights 47
Aug 29, 2017: Aequus Provides Second Quarter 2017 Operational Highlights 49
May 30, 2017: Aequus Provides First Quarter 2017 Financial Highlights 51
May 01, 2017: Aequus Provides Fourth Quarter and Fiscal 2016 Financial Highlights 52
Product News 54
09/07/2017: Aequus Announces Positive Results for Proof of Concept Clinical Trial of Anti-Nausea Patch 54
04/03/2017: Aequus Announces Positive Results from Second Proof of Concept Study for Long-Acting Aripiprazole Transdermal Patch 55
02/01/2017: Aequus Receives Non-Dilutive Funding from the Government of Canada to Support Aripiprazole Patch Development 56
Product Approvals 57
Mar 07, 2018: FDA Confirms Date to Providing Regulatory Guidance for Aequus’ Anti-Nausea Patch 57
Jan 31, 2018: Aequus and Camargo Prepare for Meeting with FDA to Advance Anti-Nausea Patch 58
Aug 24, 2017: Aequus Announces Abbreviated Development Path for Transdermal Aripiprazole 59
Jun 15, 2017: Aequus Advances Clinical Development of Transdermal Anti-Nausea Patch 60
Jan 09, 2017: Aequus Initiates Second Proof of Concept Clinical Trial of Transdermal Aripiprazole Patch 61
Clinical Trials 62
Jul 05, 2017: Aequus Receives Approval from Health Canada to Initiate Proof of Concept Clinical Trial of Anti-Nausea Patch 62
Feb 14, 2017: Aequus Successfully Completes Dosing in Second Proof of Concept Clinical Trial of Transdermal Aripiprazole Patch 63
Appendix 64
Methodology 64
About GlobalData 64
Contact Us 64
Disclaimer 64
Aequus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Aequus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Aequus Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Aequus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Aequus Pharmaceuticals Inc, Deals By Therapy Area, 2012 to YTD 2018 9
Aequus Pharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 10
Aequus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Aequus Pharma Raises USD0.6 Million in Venture Financing 13
Aequus Pharma Raises US$1.2 Million In First Round Of Venture Financing 14
Aequus Pharma Enters into Agreement with Ehave 15
CannaRoyalty and Aequus Pharma Enter into Agreement 16
Aequus Pharma to Enter into Agreement with Scientus Pharma 17
Aequus Pharma Enters into Agreement with Santen 18
Aequus Pharma and Centre for Drug Research and Development Enter into a Research Agreement 19
Aequus Pharma Enters into Co-Development Agreement with Corium International 20
Aequus Pharma Enters into Co-Development Agreement with Corium International 21
Aequus Pharma to Enter into Licensing Agreement with Transdermal Research Pharm Labs 22
Aequus Pharma Enters into Licensing Agreement with Supernus Pharma 23
Aequus Pharma Enters Into Licensing Agreement With Transdermal Research Pharm Labs For Transdermal Delivery Of Aripiprazole 24
Aequus Pharma Raises USD0.2 Million in Private Placement of Units 25
Aequus Pharma Raises USD0.6 Million in Private Placement of Units 26
Aequus Raises USD0.2 Million in Private Placement of Units 28
Aequus Pharma Plans to Raise up to USD15.7 Million in Public Offering 29
Aequus Pharma Raises USD3.9 Million in Public Offering of Units 30
Aequus Pharma Raises USD2 Million in Public Offering of Shares 32
Aequus Pharma Raises USD1.3 Million in Public Offering of Shares 33
Aequus Pharma Raises USD0.6 Million in Private Placement of Shares 34
Aequus Pharma Raises USD1 Million in Public Offering of Shares 35
Aequus Pharma Raises USD3.3 Million in Private Placement of Warrants 36
Aequus Pharma Raises USD0.4 Million in Private Placement of Warrants 37
Aequus Pharma Acquires TeOra Health 38
Aequus Pharmaceuticals Inc, Key Competitors 39
Aequus Pharmaceuticals Inc, Key Employees 40
Aequus Pharmaceuticals Inc, Subsidiaries 41
List of Figures
Aequus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Aequus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Aequus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Aequus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Aequus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Aequus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Aequus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Aequus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Aequus Pharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 10